BioNTech SE Ownership | Who Owns BioNTech SE?

BioNTech SE Ownership Summary

BioNTech SE is owned by 18.63% institutional investors, 57.51% insiders, and 23.86% retail investors. Fmr is the largest institutional shareholder, holding 2.99% of BNTX shares. Franklin All Country World ex US Equity is the top mutual fund, with 8.32% of its assets in BioNTech SE shares.

BNTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	BioNTech SE	18.63%	57.51%	23.86%
Sector	Healthcare Stocks	244.59%	12.11%	-156.70%
Industry	Biotech Stocks	379.61%	11.70%	-291.31%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	7.57M	2.99%	$704.56M
Primecap management co/ca/	3.77M	1.49%	$350.99M
Dodge & cox	3.68M	1.45%	$342.20M
Flossbach von storch	2.23M	0.88%	$207.14M
T. rowe price investment management	2.07M	0.82%	$192.19M
Blackrock	1.90M	0.79%	$152.32M
Blackrock funding, inc. /de	1.85M	0.73%	$172.60M
Temasek (private)	1.51M	0.60%	$140.14M
Bnp paribas arbitrage, snc	1.32M	0.52%	$122.78M
Logos global management lp	1.01M	0.40%	$94.45M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bill & melinda gates foundation	148.67K	19.99%	$11.95M
Gsk	889.82K	13.75%	$82.80M
Davern capital partners, lp	754.55K	11.97%	$70.21M
Logos global management lp	1.01M	4.07%	$94.45M
Sectoral asset management	41.87K	2.72%	$3.90M
Krensavage asset management	59.52K	2.10%	$5.54M
Tang capital management	470.00K	1.99%	$43.73M
Patient square capital lp	134.43K	1.94%	$12.51M
Crocodile capital partners gmbh	29.59K	1.87%	$2.75M
Long focus capital management	624.00K	1.48%	$58.06M

Top Buyers

Holder	Shares	% Assets	Change
Fmr	7.57M	0.03%	1.86M
Logos global management lp	1.01M	4.07%	1.01M
Goldman sachs group	589.90K	0.00%	493.07K
Davern capital partners, lp	754.55K	11.97%	449.50K
Assenagon asset management	423.26K	0.05%	423.26K

Top Sellers

Holder	Shares	% Assets	Change
T. rowe price investment management	2.07M	0.13%	-3.79M
Pfizer	-	-	-1.66M
Flossbach von storch	2.23M	0.94%	-1.45M
Capital investors	-	-	-1.13M
Capital world investors	-	-	-955.98K

New Positions

Holder	Shares	% Assets	Change	Value
Logos global management lp	1.01M	4.07%	1.01M	$94.45M
Assenagon asset management	423.26K	0.05%	423.26K	$39.38M
Point72 asset management	327.18K	0.03%	327.18K	$30.44M
Sixth street partners management company	211.76K	0.00%	211.76K	$19.70M
Price t rowe associates inc /md/	161.83K	0.00%	161.83K	$15.06M

Sold Out

Holder	Change
Cornerstone planning group	-1.00
Halbert hargrove global advisors	-1.00
Gps wealth strategies group	-1.00
Clear street markets	-1.00
Harbor investment advisory	-1.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	313	3.64%	47,117,051	-0.84%	18	4.82%	138	2.99%	70	-5.41%
Mar 31, 2026	291	-8.49%	46,165,527	-3.61%	19	4.76%	129	-12.24%	72	-10.00%
Dec 31, 2025	143	-50.35%	16,971,235	-66.39%	7	1.62%	60	-43.40%	37	-59.78%
Sep 30, 2025	105	-62.09%	20,093,114	-62.09%	8	1.71%	36	-70.97%	37	-51.32%
Jun 30, 2025	283	-8.41%	53,736,135	4.22%	22	4.86%	122	11.93%	80	-22.33%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Franklin All Country World ex US Equity	20.00M	8.32%	20.00M
Fidelity Contrafund	3.28M	1.30%	727.73K
Dodge & Cox International Stock I	2.52M	1.00%	-
FvS SICAV Multiple Opportunities F	2.43M	0.97%	-
T. Rowe Price Capital Appreciation	2.27M	0.90%	-
Vanguard Capital Opportunity Inv	2.19M	0.87%	-
Harding Loevner International Eq Instl	1.29M	0.54%	-561.45K
Fidelity Contrafund Commingled Pl Cl S	1.27M	0.51%	275.03K
T. Rowe Price US Mid-Cap Growth Equity	1.02M	0.40%	-687.00
T. Rowe Price Mid-Cap Growth	1.02M	0.40%	-245.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 08, 2026	Sahin Ugur	Chief Executive Officer	Sell	$3.67M
Sep 09, 2026	Sahin Ugur	Chief Executive Officer	Sell	$3.52M
Sep 03, 2026	Sahin Ugur	Chief Executive Officer	Sell	$4.63M
Sep 04, 2026	Sahin Ugur	Chief Executive Officer	Sell	$3.26M
Apr 22, 2026	Poetting Sierk	Chief Operating Officer	Sell	$5.53M

Insider Transactions Trends

Date	Buy	Sell
2029 Q2	-	-
2027 Q2	-	-
2026 Q2	-	-
2026 Q1	-	-
2025 Q2	-	-

BNTX Ownership FAQ

Who Owns BioNTech SE?

BioNTech SE shareholders are primarily institutional investors at 18.63%, followed by 57.51% insiders and 23.86% retail investors. The average institutional ownership in BioNTech SE's industry, Biotech Stocks , is 379.61%, which BioNTech SE falls below.

Who owns the most shares of BioNTech SE?

BioNTech SE’s largest shareholders are Fmr (7.57M shares, 2.99%), Primecap management co/ca/ (3.77M shares, 1.49%), and Dodge & cox (3.68M shares, 1.45%). Together, they hold 5.94% of BioNTech SE’s total shares outstanding.

Does Blackrock own BioNTech SE?

Yes, BlackRock owns 0.79% of BioNTech SE, totaling 1.9M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 152.32M$. In the last quarter, BlackRock decreased its holdings by -11.414K shares, a -0.60% change.

Who is BioNTech SE’s biggest shareholder by percentage of total assets invested?

Bill & melinda gates foundation is BioNTech SE’s biggest shareholder by percentage of total assets invested, with 19.99% of its assets in 148.67K BioNTech SE shares, valued at 11.95M$.

Who is the top mutual fund holder of BioNTech SE shares?

Franklin All Country World ex US Equity is the top mutual fund holder of BioNTech SE shares, with 8.32% of its total shares outstanding invested in 20M BioNTech SE shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools